The work of our Healthcare business can help to make a difference to millions of lives. We put our patients at the center of everything we do.

Our Healthcare business aims to change lives

With a holistic approach, we design and develop medicines and intelligent devices that strive to provide ongoing care for patients beyond their treatment. This includes medications to treat conditions such as cancer or multiple sclerosis (MS). For example, we offer an injection device and disease monitoring software outside USA and Canada that allow patients with MS to self-inject their medicine and track its administration. With cancer, we are researching the use of biomarkers that can match potential treatment to individual patients.

Our goal is to support people at various stages of life. We have helped many women and couples achieve their dream of having a baby. As a global market leader in fertility treatments, we do what we do with passion – and we think further ahead. That’s why we complemented our legacy in fertility drug treatments with the launch of a dedicated Fertility Technologies unit to help improve treatment outcomes in the lab.

Our purpose. Our patients.

We are united As One for Patients to help create, improve and prolong lives.

This is our purpose – the reason why we do what we do every day. Working As One for Patients motivates us to always give our best and continuously improve our efforts.

Because we understand that every single one of us, every decision and contribution we make in our work has an impact on the lives of patients and their caregivers.

We are united As One for Patients.

Our therapeutic areas


In 2018, it is estimated that more than 9.5 million people died from cancer and that number is expected to increase.

Explore More

  1. Oncology

Neurology & Immunology

We have more than 20 years of experience in Multiple Sclerosis (MS) care, and remain committed to finding solutions for patients’ significant unmet needs.

Explore More


General Medicine

We combine our expertise in diabetes, cardiovascular diseases and thyroid disorders to provide access to healthcare solutions.

Explore More

  2. Cardiovascular Diseases


With our broad portfolio of treatment options, devices and advanced fertility technologies, we aim to contribute to improved treatment outcomes that help couples fulfill the dream of parenthood.

Explore More


Vibrant Thoughts Blog

Science and technology are transforming how we understand disease. Discover the people behind this innovation, and the vibrant thinking that drives them to make a difference for patients.

Explore More

  1. Vibrant Thoughts Blog

Related News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Collaborates with Research Groups Based in ...

    Merck KGaA, Darmstadt, Germany announced a three-year collaboration with the research group of John Hartwig at University of California, Berkeley and Lawrence Berkeley National Laboratory, Berkeley, California.


  2. Press Releases

    Merck KGaA, Darmstadt, Germany Highlights Commitment to Improving Cancer Outcomes ...

    Merck KGaA, Darmstadt, Germany, announced 43 abstracts covering modalities and mechanisms will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, Chicago, Ill., US.


  3. Press Releases

    Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled ...

    The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the initiation of new patients on evobrutinib and patients with less than 70 days exposure to study medication in the U.S.


We take a patient-directed approach each day, working with patients and caregivers to systematically incorporate their perspectives throughout our processes to shape the way we design and deliver healthcare.

learn more


This publication is intended to provide information to an international audience. Not all products discussed on this page may be available in your country and local prescribing information and approved indications may differ from country to country. For local prescribing information and approved indications, please visit our local websites.